Meimei Wu
- Co-authors
- Chunli WangChu-Tian MaiXiaojun ZhangHanmin LiZiren SuYuanyuan ChengTiantian WangChengshan Guo
- Topics
- Ferroptosis and cancer prognosis (4 papers)RNA modifications and cancer (4 papers)Pharmacological Effects of Natural Compounds (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Meimei Wu
31 papers receiving 650 citations
Peers
Comparison fields: 5 of 92
- Molecular Biology 357
- Immunology 138
- Genetics 94
- Epidemiology 85
- Pharmacology 72
Countries citing papers authored by Meimei Wu
This map shows the geographic impact of Meimei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meimei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meimei Wu more than expected).
Fields of papers citing papers by Meimei Wu
This network shows the impact of papers produced by Meimei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meimei Wu. The network helps show where Meimei Wu may publish in the future.
Co-authorship network of co-authors of Meimei Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Meimei Wu. A scholar is included among the top collaborators of Meimei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meimei Wu. Meimei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 0 | |
| 6 | 10 | |
| 7 | 2 | |
| 8 | 4 | |
| 9 | 4 | |
| 10 | 6 | |
| 11 | 16 | |
| 12 | 17 | |
| 13 | 5 | |
| 14 | 12 | |
| 15 | 166 | |
| 16 | 8 | |
| 17 | 59 | |
| 18 | 23 | |
| 19 | 159 | |
| 20 | 6 |
About Meimei Wu
Meimei Wu is a scholar working on Molecular Medicine, Pharmacology and Behavioral Neuroscience, having authored 33 papers that have together received 653 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (4 papers), RNA modifications and cancer (4 papers) and Pharmacological Effects of Natural Compounds (3 papers). The work is most often cited by research in Nephrology (65 citations), Pharmacology (72 citations) and Molecular Medicine (40 citations). Meimei Wu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Chunli Wang, Chu-Tian Mai, Xiaojun Zhang, Hanmin Li, Ziren Su, Yuanyuan Cheng, Tiantian Wang, Xiaojun Zhang, Chengshan Guo and Xin Zhang. Their work appears in journals such as Journal of Neuroscience, Frontiers in Immunology and BMC Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.